InterCure
InterCure is a medical device company focused on respiratory treatment that has developed and patented a technology platform.
Launch date
Market cap
$84.6m
Enterprise valuation
$118m (Public information from Sep 2024)
Share price
ILS7.039 INCR.TA
Company register number 512051699
Ra'anana Center District (HQ)
Financials
Estimates*
| ILS | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenues | - | 8.9m | 65.0m | 220m | 389m | 391m | 1.3b |
| % growth | - | - | 629 % | 238 % | 77 % | 1 % | 235 % |
| EBITDA | - | (21.2m) | 1.8m | 37.6m | 64.5m | 46.6m | (31.3m) |
| % EBITDA margin | - | (238 %) | 3 % | 17 % | 17 % | 12 % | (2 %) |
| Profit | - | (3.0m) | (37.2m) | 4.7m | 44.8m | (62.0m) | (70.4m) |
| % profit margin | - | (34 %) | (57 %) | 2 % | 12 % | (16 %) | (5 %) |
| EV / revenue | - | 44.1x | 6.3x | 3.8x | 1.5x | 0.8x | 0.1x |
| EV / EBITDA | - | -18.6x | 225.8x | 22.5x | 8.9x | 6.6x | -1.9x |
| R&D budget | - | 1.7m | 1.6m | 1.2m | <1m | <1m | - |
| R&D % of revenue | - | 19 % | 2 % | 1 % | - | - | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
$5.4m | Series A | ||
| N/A | $3.5m | Early VC | |
$4.5m | Series B | ||
$3.0m | Series C | ||
| N/A | N/A | IPO | |
| N/A | $8.0m | Post IPO Equity | |
| Total Funding | $16.4m | ||
Recent News about InterCure
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
